衰老细胞清除剂在心血管疾病中的研究进展

doi:10.3760/cma.j.issn.1007-1245.2022.14.031

摘要/Abstract

摘要： 老龄化是导致冠心病、心力衰竭、心肌梗死等心血管疾病的首要危险因素，并因免疫力下降、恢复期较长等原因导致了此类疾病的预后不良；同时心血管疾病也是40% 65岁以上人群死亡的主要原因。衰老细胞可以通过促炎和促纤维化分泌蛋白的表达来加速心血管疾病的进展，已有研究表明，一些靶向药物可以诱导衰老细胞凋亡，而这些选择性清除衰老细胞的化合物被定义为衰老细胞清除剂（Senolytics）。本文将关注衰老细胞清除剂在冠心病、心力衰竭、心肌梗死等方面的研究进展，并作一综述。

关键词: 细胞衰老, 衰老细胞清除剂, 心力衰竭, 心肌梗死, 冠心病

Abstract: Aging is the primary risk factor of cardiovascular diseases such as coronary artery disease, heart failure, and myocardial infarction. The poor prognosis of these diseases is caused by the decline of immunity and long recovery period. At the same time, cardiovascular diseases have been the leading cause of death in 40% of individuals over 65 years old. Senescent cells can accelerate the progression of cardiovascular diseases by expressing pro-inflammatory and pro-fibrotic secreted proteins. It has been shown that some targeted drugs can induce the apoptosis of senescent cells, and these bioactive compounds that preferentially remove senescent cells are known as Senolytics. This paper focuses on the research progress of Senolytics in coronary heart disease, heart failure, myocardial infarction, and so on.

Key words: Senescence, Senolytics, Heart failure, Myocardial infarction, Coronary heart disease

刘婧玚孙经武刘振石新烨董文敬. 衰老细胞清除剂在心血管疾病中的研究进展[J]. 国际医药卫生导报, 2022, 28(14): 2062-2065.

Liu Jingyang, Sun Jingwu, Liu Zhen, Shi Xinye, Dong Wenjing. Research progress on Senolytics in cardiovascular diseases [J]. International Medicine and Health Guidance News, 2022, 28(14): 2062-2065.

参考文献

[1] Fumagalli M, Rossiello F, Clerici M, et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation[J]. Nat Cell Biol, 2012, 14(4): 355-365. DOI: 10.1038/ncb2466.
[2] Anderson R, Lagnado A, Maggiorani D, et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence[J]. EMBO J, 2019, 38(5) :e100492. DOI: 10.15252/embj.2018100492..
[3] Hewitt G, Jurk D, Marques FD, et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence[J]. Nat Commun, 2012, 3: 708. DOI: 10.1038/ncomms1708.
[4] Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease: from mechanisms to therapy[J]. Nat Med, 2015, 21(12): 1424-1435. DOI: 10.1038/nm.4000.
[5] Watanabe S, Kawamoto S, Ohtani N, et al. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases[J]. Cancer Sci, 2017, 108(4): 563-569. DOI: 10.1111/cas.13184.
[6] Demaria M, Ohtani N, Youssef S A, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA[J]. Dev Cell, 2014, 31(6): 722-733. DOI: 10.1016/j.devcel.2014.11.012.
[7] Storer M, Mas A, Robert-Moreno A, et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning[J]. Cell, 2013, 155(5): 1119-1130. DOI: 10.1016/j.cell.2013.10.041.
[8] Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: defining a path forward[J]. Cell, 2019, 179(4): 813-827. DOI: 10.1016/j.cell.2019.10.005.
[9] Childs BG, Baker DJ, Wijshake T, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis[J]. Science, 2016, 354(6311): 472-477. DOI: 10.1126/science.aaf6659.
[10] Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan[J]. Nature, 2016, 530(7589): 184-189. DOI: 10.1038/nature16932.
[11] Dookun E, Passos JF, Arthur HM, et al. Therapeutic potential of senolytics in cardiovascular disease[J]. Cardiovasc Drugs Ther, 2022, 36(1): 187-196. DOI: 10.1007/s10557-020-07075-w.
[12] Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence[J]. Aging Cell, 2010, 9(5): 667-684. DOI: 10.1111/j.1474-9726.2010.00608.x.
[13] Soto-Gamez A, Quax WJ, Demaria M. Regulation of survival networks in senescent cells: from mechanisms to interventions[J]. J Mol Biol, 2019, 431(15): 2629-2643. DOI: 10.1016/j.jmb.2019.05.036.
[14] Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles heel of senescent cells from transcriptome to senolytic drugs[J]. Aging Cell, 2015, 14(4):644-658. DOI:10.1111/acel.12344.
[15] Kirkland JL, Tchkonia T. Cellular senescence: a translational perspective[J]. EBioMedicine, 2017, 21: 21-28. DOI: 10.1016/j.ebiom.2017.04.013.
[16] Short S, Fielder E, Miwa S, et al. Senolytics and senostatics as adjuvant tumour therapy[J]. EBioMedicine, 2019, 41: 683-692. DOI: 10.1016/j.ebiom.2019.01.056.
[17] 龙凯琴,何进鹏,张通珊,等. 槲皮素促进电离辐射引起的衰老细胞发生凋亡[J]. 辐射研究与辐射工艺学报,2019,37(6):26-33. DOI:10.11889/j.1000-3436.2019.rrj.37.060302.
[18] Olave NC, Grenett MH, Cadeiras M, et al. Upstream stimulatory factor-2 mediates quercetin-induced suppression of PAI-1 gene expression in human endothelial cells[J]. J Cell Biochem, 2010, 111(3): 720-726. DOI: 10.1002/jcb.22760.
[19] Chang J, Wang Y, Shao L, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice[J]. Nat Med, 2016, 22(1): 78-83. DOI: 10.1038/nm.4010.
[20] 苏路路,管博文,樊飞跃,等. 衰老细胞清除剂研究进展[J]. 中国药理学通报,2019,35(10):1333-1337. DOI:10.3969/j.issn.1001-1978.2019.10.001.
[21] North BJ, Sinclair DA. The intersection between aging and cardiovascular disease[J]. Circ Res, 2012, 110(8): 1097-1108. DOI: 10.1161/CIRCRESAHA.111.246876.
[22] Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure[J]. Heart Fail Clin, 2012, 8(1): 143-164. DOI: 10.1016/j.hfc.2011.08.011.
[23] Walaszczyk A, Dookun E, Redgrave R, et al. Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction[J]. Aging Cell, 2019, 18(3): e12945. DOI: 10.1111/acel.12945.
[24] Lewis-Mcdougall FC, Ruchaya PJ, Domenjo-Vila E, et al. Aged-senescent cells contribute to impaired heart regeneration[J]. Aging Cell, 2019, 18(3): e12931. DOI: 10.1111/acel.12931.
[25] Bergmann O, Zdunek S, Felker A, et al. Dynamics of cell generation and turnover in the human heart[J]. Cell, 2015, 161(7): 1566-1575. DOI: 10.1016/j.cell.2015.05.026.
[26] Richardson GD, Laval S, Owens WA. Cardiomyocyte regeneration in the mdx mouse model of nonischemic cardiomyopathy[J]. Stem Cells Dev, 2015, 24(14): 1672-1679. DOI: 10.1089/scd.2014.0495.
[27] Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. the investigators of the gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI-2)[J]. N Engl J Med, 1993, 329(20):1442-1448. DOI: 10.1056/NEJM199311113292002.
[28] Zhu F, Li Y, Zhang J, et al. Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction[J]. PLoS One, 2013, 8(9): e74535. DOI: 10.1371/journal.pone.0074535.
[29] Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease[J]. Nat Commun, 2017, 8: 14532. DOI: 10.1038/ncomms14532.
[30] Song P, Zhao Q, Zou MH. Targeting senescent cells to attenuate cardiovascular disease progression[J]. Ageing Res Rev, 2020, 60: 101072. DOI: 10.1016/j.arr.2020.101072.
[31] Stojanovic SD, Fiedler J, Bauersachs J, et al. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis[J]. Eur Heart J, 2020, 41(31): 2983-2996. DOI: 10.1093/eurheartj/ehz919.
[32] Roos CM, Zhang B, Palmer AK, et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice[J]. Aging Cell, 2016, 15(5): 973-977. DOI: 10.1111/acel.12458.
[33] 孟君,王淑伟,荆全民. 半乳糖凝集素-3和氨基末端脑钠肽前体对射血分数保留的心力衰竭诊断及预后评价的价值[J]. 中国实验诊断学,2019,23(10):1739-1741. DOI:10.3969/j.issn.1007-4287.2019.10.017.
[34] Durik M, Kavousi M, Van Der Pluijm I, et al. Nucleotide excision DNA repair is associated with age-related vascular dysfunction[J]. Circulation, 2012, 126(4): 468-478. DOI: 10.1161/CIRCULATIONAHA.112.104380.
[35] Cafueri G, Parodi F, Pistorio A, et al. Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition[J]. PLoS One, 2012, 7(4): e35312. DOI: 10.1371/journal.pone.0035312.
[36] Balint B, Yin H, Nong Z, et al. Seno-destructive smooth muscle cells in the ascending aorta of patients with bicuspid aortic valve disease[J]. EBioMedicine, 2019, 43: 54-66. DOI: 10.1016/j.ebiom.2019.04.060.
[37] Wiley CD, Liu S, Limbad C, et al. SILAC analysis reveals increased secretion of hemostasis-related factors by senescent cells[J]. Cell Rep, 2019, 28(13): 3329-3337.e5. DOI: 10.1016/j.celrep.2019.08.049.